Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : EuCorVac-19
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : EuBiologics
Deal Size : Inapplicable
Deal Type : Inapplicable
POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial
Details : EuCorVac-19, a recombinant protein vaccine displaying the SARS-CoV-2 receptor-binding domain (RBD) antigen on the immunogenic liposomes, which is present top line interim results of a Phase 3 clinical trial.
Product Name : EuCorVac-19
Product Type : Vaccine
Upfront Cash : Inapplicable
July 14, 2023
Lead Product(s) : EuCorVac-19
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : EuBiologics
Deal Size : Inapplicable
Deal Type : Inapplicable